ABBV

AbbVie Inc.

HealthcareDrug Manufacturers - GeneralUSUSDPeers →

$234.89

-0.62%LiveJun 24, 2026

Market cap

$415B

52w range

181.73 – 244.81

P / E

—

EPS · FY 2025

$2.37

Volume

7.27M

Revenue · FY 2025

$61.16B

+8.57% YoY

Explain this page

Arphra AIPlain-English read on AbbVie Inc.’s valuation

Revenue · 5Y

$61.16B+8.6%

FY21FY22FY23FY24FY25

Net income · 5Y

$4.23B-1.2%

FY21FY22FY23FY24FY25

Margins · FY2025

Gross margin70.2%

Operating margin32.8%

Net margin6.9%

FCF margin29.1%

income_statement_annual

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	YoY
Revenue	61.16B	56.33B	54.32B	58.05B	56.20B	+8.6%
Gross profit	42.96B	39.43B	33.90B	40.64B	38.75B	+8.9%
R&D	9.10B	12.79B	7.67B	6.51B	8.05B	-28.9%
Operating income	20.09B	9.14B	12.76B	18.12B	17.92B	+119.9%
Net income	4.23B	4.28B	4.86B	11.84B	11.54B	-1.2%
Diluted EPS	2.37	2.39	2.72	6.63	6.45	-0.8%
Net margin	6.9%	7.6%	9.0%	20.4%	20.5%	—

Pro

Full income statement, balance sheet, and cash-flow history is included with Pro.